Xuzhishi Technology develops brain-disease treatment products using brain imaging, VR, AR and AI, including a cognitive rehabilitation system.
Xuzhishi Technology develops brain-disease treatment products using brain imaging, VR, AR and AI, including the YKVR-1 cognitive rehabilitation system and a VR stroke limb rehabilitation system. Its products are used in hospitals, medical institutions and nursing homes, and it holds EU CE and UK MHRA certification. Established in 2015 in Hangzhou, China, it raised CNY 50 million in Series A+ funding in December 2025 from Zheshang Capital Management, XT Venture and Plum Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in